Comparative study on the bioavailability and bioequivalence of rifapentine capsules in humans.

These results indicate no statistically significant differences between the formulations for ln AUC 0-84 , ln AUC 0- ∞ , and ln C max ; no statistically significant period differences for ln C max ; however, significant period differences exist for ln AUC 0-84 and ln AUC 0- ∞ (P < 0.05); and highly significant inter-individual differences for ln AUC 0-84 , ln AUC 0- ∞ , and ln C max (P < 0.001).

also in 132,142 other papers